These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21618217)

  • 1. Monocytes enhance cell proliferation and LMP1 expression of nasal natural killer/T-cell lymphoma cells by cell contact-dependent interaction through membrane-bound IL-15.
    Ishii H; Takahara M; Nagato T; Kis LL; Nagy N; Kishibe K; Harabuchi Y; Klein E
    Int J Cancer; 2012 Jan; 130(1):48-58. PubMed ID: 21618217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant increase of LMP1 and CD25 (IL-2-receptor alpha) expression induced by IL-10 in the EBV-positive NK lines SNK6 and KAI3.
    Takahara M; Kis LL; Nagy N; Liu A; Harabuchi Y; Klein G; Klein E
    Int J Cancer; 2006 Dec; 119(12):2775-83. PubMed ID: 17013900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human interleukin-10 expression in T/natural killer-cell lymphomas: association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas.
    Boulland ML; Meignin V; Leroy-Viard K; Copie-Bergman C; Brière J; Touitou R; Kanavaros P; Gaulard P
    Am J Pathol; 1998 Oct; 153(4):1229-37. PubMed ID: 9777954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble ICAM-1 secretion and its functional role as an autocrine growth factor in nasal NK/T cell lymphoma cells.
    Takahara M; Nagato T; Komabayashi Y; Yoshino K; Ueda S; Kishibe K; Harabuchi Y
    Exp Hematol; 2013 Aug; 41(8):711-8. PubMed ID: 23583640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients.
    Nagato T; Kobayashi H; Kishibe K; Takahara M; Ogino T; Ishii H; Oikawa K; Aoki N; Sato K; Kimura S; Shimizu N; Tateno M; Harabuchi Y
    Clin Cancer Res; 2005 Dec; 11(23):8250-7. PubMed ID: 16322282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LMP1 promotes nasal NK/T-cell lymphoma cell function by eIF4E via NF-κB pathway.
    Sun L; Zhao Y; Shi H; Ma C; Wei L
    Oncol Rep; 2015 Dec; 34(6):3264-71. PubMed ID: 26397141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CD70 in nasal natural killer/T cell lymphoma cell lines and patients; its role for cell proliferation through binding to soluble CD27.
    Yoshino K; Kishibe K; Nagato T; Ueda S; Komabayashi Y; Takahara M; Harabuchi Y
    Br J Haematol; 2013 Feb; 160(3):331-42. PubMed ID: 23206232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus BART9 miRNA modulates LMP1 levels and affects growth rate of nasal NK T cell lymphomas.
    Ramakrishnan R; Donahue H; Garcia D; Tan J; Shimizu N; Rice AP; Ling PD
    PLoS One; 2011; 6(11):e27271. PubMed ID: 22102884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal natural killer/T-cell lymphoma and its association with type "i"/XhoI loss strain Epstein-Barr virus in Chile.
    Cabrera ME; Eizuru Y; Itoh T; Koriyama C; Tashiro Y; Ding S; Rey S; Akiba S; Corvalan A
    J Clin Pathol; 2007 Jun; 60(6):656-60. PubMed ID: 16775124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin-dependent kinase 1 and survivin as potential therapeutic targets against nasal natural killer/T-cell lymphoma.
    Nagato T; Ueda S; Takahara M; Kishibe K; Komabayashi Y; Kumai T; Ohara K; Hirata-Nozaki Y; Harabuchi S; Hayashi R; Ohkuri T; Bernasconi M; Nadal D; Kobayashi H; Harabuchi Y
    Lab Invest; 2019 May; 99(5):612-624. PubMed ID: 30664711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of the 30 base pair deletion of Epstein-Barr virus latent membrane protein 1 in extranodal nasal type NK/T-cell lymphoma and its prognostic significance].
    Zhao S; Liu WP; Wang XL; Zhang WY; Jiang W; Tang Y; Li GD
    Zhonghua Bing Li Xue Za Zhi; 2005 Nov; 34(11):720-3. PubMed ID: 16536316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of miR-15a due to LMP1 promotes cell proliferation and predicts poor prognosis in nasal NK/T-cell lymphoma.
    Komabayashi Y; Kishibe K; Nagato T; Ueda S; Takahara M; Harabuchi Y
    Am J Hematol; 2014 Jan; 89(1):25-33. PubMed ID: 23963825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal natural killer (NK)/T-cell lymphoma: clinical, histological, virological, and genetic features.
    Harabuchi Y; Takahara M; Kishibe K; Moriai S; Nagato T; Ishii H
    Int J Clin Oncol; 2009 Jun; 14(3):181-90. PubMed ID: 19593607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Extranodal nasal type NK/T-cell lymphoma: the expression of Epstein-Barr virus latent membrane protein 1 and its significance of prognosis].
    Zhao S; Liu WP; Zhang WY; Li GD
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 May; 36(3):338-40. PubMed ID: 15931862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasopharyngeal/nasal type T/NK lymphomas: analysis of 14 cases and review of the literature.
    García-Cosío M; Santón A; Méndez MC; Rivas C; Martín C; Bellas C
    Tumori; 2003; 89(3):278-84. PubMed ID: 12908783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EBV induces persistent NF-κB activation and contributes to survival of EBV-positive neoplastic T- or NK-cells.
    Takada H; Imadome KI; Shibayama H; Yoshimori M; Wang L; Saitoh Y; Uota S; Yamaoka S; Koyama T; Shimizu N; Yamamoto K; Fujiwara S; Miura O; Arai A
    PLoS One; 2017; 12(3):e0174136. PubMed ID: 28346502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a novel human natural killer-cell line (NK-YS) established from natural killer cell lymphoma/leukemia associated with Epstein-Barr virus infection.
    Tsuchiyama J; Yoshino T; Mori M; Kondoh E; Oka T; Akagi T; Hiraki A; Nakayama H; Shibuya A; Ma Y; Kawabata T; Okada S; Harada M
    Blood; 1998 Aug; 92(4):1374-83. PubMed ID: 9694726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nodal T/NK-cell lymphoma of nasal type: a clinicopathological study of six cases.
    Takahashi E; Asano N; Li C; Tanaka T; Shimada K; Shimada S; Yoshino T; Kojima M; Hara K; Eimoto T; Nakamura S
    Histopathology; 2008 Apr; 52(5):585-96. PubMed ID: 18370955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease.
    Chiang AK; Tao Q; Srivastava G; Ho FC
    Int J Cancer; 1996 Nov; 68(3):285-90. PubMed ID: 8903467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mTOR inhibitors induce cell-cycle arrest and inhibit tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cells.
    Kawada J; Ito Y; Iwata S; Suzuki M; Kawano Y; Kanazawa T; Siddiquey MN; Kimura H
    Clin Cancer Res; 2014 Nov; 20(21):5412-22. PubMed ID: 25208880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.